Background: Leukemia is the most frequently occurring cancer in children. Although its etiology is largely unknown, leukemia is believed to result from an interaction between genetic and environmental factors. Among different potential risk factors, the possible role of maternal alcohol consumption during pregnancy has been questioned.
Introduction
Leukemia is the most common childhood cancer. The incidence rate of leukemia in children has increased in the United States and Europe in the last decades (1, 2) . Among acute leukemia (AL), acute lymphoblastic leukemia (ALL) is the most frequent, followed by acute myeloid leukemia (AML) also called acute non-lymphoblastic leukemia, for which eight different subtypes of AML (M0-M7) have been characterized. Some evidence from descriptive and etiologic epidemiology suggests that leukemia could be initiated during prenatal development or early childhood. First, early incidence peaks are observed for both ALL and AML. In developed countries, the incidence of ALL is characterized by a peak among 2-to 3-year-old children, it declines until age 8 to 10 years and remains stable thereafter. In contrast, the incidence rates of AML are highest in children ages 0 to 2 years, is fairly uniform in older children, and then increases through the adolescent years (3) . Second, although the etiology of childhood leukemia remains largely unknown, it may result from an interaction between host susceptibility genetic factors and environmental carcinogenic factors during pregnancy. On one hand, it is now considered that similar with other cancers, the natural history of leukemia includes two or more genetic and/or epigenetic events (4) . Children with certain genetic conditions have a higher risk of developing leukemia than those of the general population. In particular, children with Down syndrome (DS) are highly susceptible to AL (5) . Studies in twins with concordant leukemias and in archived newborn blood spots have provided evidence that childhood leukemia is initiated in utero (6) . The majority of chromosome translocations arise during fetal hematopoiesis. In addition, at least one mutation type has been found to occur prenatally in DS patients with AML-M7 (7) . On the other hand, few prenatal nongenetic risk factors of childhood leukemia have been identified thus far. Prenatal exposure to X-rays is a generally accepted risk factor. Maternal exposures during pregnancy to tobacco, alcohol, viruses, pesticides and medications have been also suspected to play a role but the evidence is still limited or inconsistent (8) .
Among the potential nongenetic risk factors, in utero exposure to alcohol is of particular interest. Indeed, alcoholic beverages are recognized as carcinogenic for humans (9) . The ethanol consumed by a pregnant woman crosses the placental barrier. Acetaldehyde, its metabolite, could exert a mutagenic activity in the fetus. Outside the ethanol metabolism, acetaldehyde could also be directly ingested by the mother from alcoholic beverages (10) . In addition, alcohol could modify the methylation status of the genome in interaction with the folate status. Such mechanisms have been reported to be involved in fetal alcohol syndrome (11) , and in the development of co-occurring childhood neuroblastoma (12) . It can be hypothesized that they might also cooperate with genetic lesions inherited or induced by other environmental factors and contribute to the development of childhood leukemia.
The association of maternal alcohol consumption during pregnancy and the risk of childhood leukemia has been investigated in several epidemiologic studies. We did a systematic review and meta-analysis of published data to summarize the existing evidence and contribute to clarify the possible association between the risk of childhood leukemia and maternal alcohol intake during pregnancy.
Materials and Methods
Data sources. We searched PubMed for studies published up to May 7, 2009 . Indexed publications were searched with the limits "MeSH terms" and "all child: 0-18 years", without language restriction, using the following terms: leukemia AND ([(alcohol drinking OR alcoholic beverages OR ethanol OR acetaldehyde OR risk OR risk factor OR risk assessment OR food) AND (pregnancy OR maternal exposure OR prenatal exposure delayed effects OR maternal-fetal exchange OR prenatal nutrition physiology OR parents)] OR fetal alcohol syndrome). In-process publications (not yet indexed in PubMed), were searched using the corresponding entry terms. In addition, we examined the reference list of relevant articles and reviews.
Inclusion criteria. Original research articles were selected when they provided the odds ratio (OR) and 95% confidence interval (95% CI) of childhood ALL, AML (or acute non-lymphoblastic leukemia), or grouped leukemias (GL) in relation to maternal alcohol consumption during pregnancy, or number of cases and controls required to calculate crude OR.
Unpublished data collection. We contacted authors to obtain complementary data when alcohol intake was mentioned but ORs and 95% CIs were not provided in the publication or when an overlap between studies was suspected.
Data extraction. Data from each study included was extracted independently by two investigators using a standardized data collection form, and then compared. Data extracted were study design, first author, publication year, country, case recruitment period, number and characteristics of cases and controls, alcohol consumption assessment (questionnaire or interview: level of intake, type of alcohol), participation rate of cases and controls, age of children, leukemia type (GL, ALL, AML), control for confounding, and additional information considered important for the analysis or discussion.
Statistical analysis. Summary OR associated with any alcohol intake during pregnancy compared with no alcohol intake (yes versus no) and corresponding 95% CI were estimated with the method of DerSimonian and Laird (13) when at least three studies were available. Random effects models were used to account for differences in population, leukemia type, type of control group, assessment method of alcohol intake, and control for potential confounders (13) . Two studies did not provide OR for "yes versus no" comparison. We calculated the OR from the data reported in one study using the method of Hamling et al. (14) and by pooling the categorical results using a fixed effect model in another study that did not provide the number of cases and controls per category level. Adjusted OR were used in all except for six studies for which only crude estimates were reported or could be calculated (Table 1) . Meta-analyses were conducted by type of leukemia, age at diagnosis, alcoholic beverage, and pregnancy trimester if at least three studies were available.
Dose-response meta-analyses were done using the method proposed by Greenland and Longnecker (15) . Dose-response slopes for an increment of one drink per week were estimated using the midpoint of each category of alcohol intake. Only studies with more than two intake levels and reporting number of cases and controls could be included in the dose-response meta-analyses. We converted alcohol intake to drinks per week, assuming that one glass or one can was equivalent to one drink.
Statistical heterogeneity between studies was evaluated with Cochran's Q test and I 2 statistics. Publication bias was assessed by constructing funnel plots and by Egger's regression asymmetry test. We investigated the following potential sources of heterogeneity: assessment method of alcohol consumption (self-reported or interview, pregnancy trimester, highest level of intake assessed), type of controls (population-or hospital-based), study size, participation rate, control for confounding, country, age at cancer diagnosis, and publication year. We conducted subgroup analyses when the number of studies allowed it or, alternatively, a visual inspection of the characteristics explaining the heterogeneity in study results. Metaregression analyses were not conducted due to the low number of studies in each subgroup. Statistical analyses were done with Stata version 9 (Stata Corp.). 
Results
Characteristics of the studies. Our search yielded a total number of 478 articles (Fig. 1) . After reviewing each publication, we identified 27 potentially eligible studies among which 6 studies were excluded. One study (16) was excluded for inappropriate outcome (leukemia grouped with lymphomas). Two studies (17, 18) were excluded for inappropriate exposure (alcohol drinking before pregnancy or alcohol use in general). One study was not included because no cases had been exposed to maternal alcohol consumption (19) (35) examined ALL and AML separately, and therefore, both reports were included in different analyses. From the article of Schüz et al., the "overall results", which comprised results from a nationwide sample and a population living in the vicinity of nuclear installations, were selected (28) . Finally, 21 studies from 20 different study populations with a total of 8,128 cases and 10,207 controls were selected and included in the meta-analyses . All studies were of case-control design. No cohort study was identified. Table 1 presents the main characteristics of the 21 casecontrol studies. Nineteen studies included children from the general population and analyzed GL, ALL, or AML. Two studies were on children with DS and reported data on GL only (33, 36) . Eight studies were conducted in Europe (22, 24, 27, 28, 34, 35, 38, 41) , eight in the United States and/or Canada and Australia (23, 25, 26, 29, 31, 32, 36, 40) , two in Mexico or Costa Rica (33, 39) , one in Japan (37), one in Taiwan (42) and one was international (30) involving eight countries. Control subjects were population-based in 15 studies and they were matched to cases on age, gender, and residence in most studies. Participation rates, mentioned only in recent studies, were above 80% in three studies (32, 35, 39) and below 50% in two studies (25, 37) . In six studies, they were lower in controls than in cases (32, 37, 38, (40) (41) (42) .
Twelve studies reported results for different types of leukemia combined. In seven of these, only acute leukemia was investigated (25, 28, 33, 34, 36, 38, 40) , in three studies (26, 30, 39) , a small percentage of other leukemias were also included, and in two studies (27, 31) , the leukemia type was not specified. Overall, the proportion of cases with ALL in these studies ranged from 36% to 89%.
Maternal alcohol consumption during pregnancy was assessed by interview in all but three studies (22, 24, 38 ) that used self-administered questionnaires. One third of the studies were focused on other risk factors and provided limited data on alcohol consumption (22, 29-31, 36, 37, 39) . Nineteen studies reported results of the comparison "yes versus no" alcohol intake during pregnancy. Nine studies reported results for more than two categories of alcohol intake (24, 26, 28, 32, 34, 35, 38, 40, 41) . The highest category of maternal alcohol consumption reported varied across studies, ranging from more than 0.5 drinks/week to more than 7 drinks/week.
Total alcohol consumption. For children from the general population, the summary of nine studies (26-28, 30, 31, 34, 38-40) including 2,940 cases indicated that alcohol consumption during pregnancy was not statistically significantly associated with risk of GL (OR "yes versus no", 1.11; 95% CI, 0.88-1.40; Fig. 2) . The heterogeneity between studies (I 2 = 62.1%) was mainly attributable to one study in a Greek population (27) showing a significant inverse association of childhood leukemia in relation to alcohol intake during pregnancy. In this study, the range of alcohol intake assessed was low and the control population was hospital-based. For children with DS, the two available studies also reported nonsignificant estimates for the risk of GL (33, 36) .
Overall, the risk of ALL was not significantly related to alcohol consumption during pregnancy compared Table 2 , ALL; Fig. 3 ). There was significant heterogeneity (I 2 = 66%) attributable to one study in Quebec, in which a significant inverse association with alcohol intake was observed (32) . This Canadian study seems to be a well-conducted study with a large sample size, an appropriate control group, and controls for confounding. Although high, the participation rate was lower in controls (84%) than in cases (96%), thus a non-response bias cannot be excluded. In addition, the difference in assessment of alcohol consumption played a role as this study queried the number of drinks per day whereas other studies queried the number of drinks per week or month. Two other studies reported inverse but not statistically significant results. One was an international study (30) including only 49 cases. The other was a Japanese study (37) , for which crude ORs for alcohol were calculated from the number of cases and controls. In this study investigating the relation of magnetic fields and childhood leukemia, participation rates were very low (49% in cases, 28.6% in controls), which raises the issue of potential selection bias (37) .
Overall, childhood AML was significantly positively associated with maternal alcohol consumption during pregnancy (OR, 1.56; 95% CI, 1.13-2.15) in nine studies (23, 24, 26, 30, 35, 37, 38, 40, 41) including 731 cases (Table 2, AML; Fig. 4 ). The association was statistically significant in three studies (24, 26, 35) , positive but not statistically significant in four studies (23, 30, 40, 41) , and not significantly inverse in two studies (37, 38) . Heterogeneity of results (I 2 = 52.5%) was mainly attributable to the Japanese study on magnetic fields and childhood leukemia with very low participation rates, as mentioned previously (37) , and a study in which only three mothers of index cases recalled any alcohol consumption during pregnancy (38) .
To investigate if the difference of association of maternal alcohol consumption during pregnancy with ALL and AML was explained by study differences, we restricted the analysis to eight studies reporting data for both ALL (22, 26, 30, 35, 37, 38, 40, 41) and AML (24, 26, 30, 35, 37, 38, 40, 41) . Again, a nonsignificant association with ALL (OR, 1.19; 95% CI, 0.98-1.45) and a significant positive association with AML (OR, 1.57; 95% CI, 1.07-2.32) were observed ( Table 2) .
Only a few studies provided enough information to be included in the dose-response meta-analyses. The results were consistent with a stronger association with AML compared with ALL, although the results were heterogeneous. The OR for an increase of a drink per (Table 3) .
Children's age. Overall, no association was found between maternal alcohol intake during pregnancy and ALL at age 0 to 4 years (OR, 1.17; 95% CI, 0.83-1.65) in three studies (24, 26, 30) . In contrast, a statistically significant association was observed for AML (OR, 2.68; 95% CI, 1.85-3.89) in five studies without heterogeneity (I 2 ≤ 0.1%; refs. 23, 24, 26, 30, 35 ; Table 2 , Fig. 5 ). Only two studies reported results of leukemia with other ages at diagnosis (23, 24) . For ALL, one study found no association in children ages 5 to 9 and 10 to 14 years (23). For AML, one study observed no association in children ages 3 to 10 years (23), whereas the other study found a significant positive association in children ages 5 to 9 years (24); both studies found no association in older children (Table 1) .
Type of alcoholic beverage. Five studies (25, 26, 32, 35, 41) provided data on beer, wine, or spirits intake, separately, whereas in one study (38) , beer and wine were combined into one group and spirits were investigated separately. Statistically significant associations were observed only for AML and wine intake (OR, 1.67; 95% CI, 1.21-2.32) and for ALL and spirits (OR, 1.29; 95% CI, 1.05-1.59; Table 2 ).
Pregnancy trimester. The risks associated with maternal alcohol consumption at different trimesters of pregnancy were examined in two studies (26, 40) for GL, three studies (26, 32, 40) for ALL, and two studies (26, 40) for AML. Overall, childhood ALL was not associated with alcohol consumption during the first trimester (OR, 0.91; 95% CI, 0.67-1.25), the second trimester (OR, 0.89; 95% CI, 0.63-1.27), or the third trimester (OR, 0.82; 95% CI, 0.62-1.10). For AML, the limited data did not allow any conclusions, although in both studies (26, 40) , the OR tended to be slightly higher when alcohol was consumed in the second and third trimesters compared with the first trimester ( Table 1) .
Publication bias. No evidence of publication bias was found when assessed by funnel plots (data not shown). However, we identified 12 studies on risk factors of childhood leukemia, other than alcohol intake during pregnancy, in which maternal alcohol consumption was considered as a potential confounder (43) (44) (45) (46) (47) (48) (49) (50) (51) (52) (53) (54) . The corresponding OR or the number of cases and controls for their computation were not given in the articles. The authors were contacted, but no workable information could be retrieved. 
Discussion
To our knowledge, this is the first meta-analysis that investigated the role of in utero exposure to alcohol associated with childhood leukemia. The results of this meta-analysis indicate that the risk of childhood AML increases with maternal alcohol consumption during pregnancy. The summary OR from nine studies for the comparison of alcohol intake during pregnancy versus no intake was 1.56 (95% CI, 1.13-2.15).
We did not observe a statistically significant association between childhood ALL and maternal alcohol intake during pregnancy. The difference of association with alcohol observed for ALL and AML was not attributable to differences between studies. When a sensitivity analysis including only the eight studies reporting data on both ALL and AML was run, alcohol intake was associated with an increased risk of AML, but not of ALL.
Due to the low number of studies with appropriate published data, the dose-response meta-analyses were not conclusive, although they are consistent with a stronger association with AML as compared with ALL. It was not possible to identify whether there was a threshold of alcohol intake in the association.
Additional studies with more detailed data on alcohol exposure are thus necessary.
Only a few studies reported results according to type of alcoholic beverage, and these were mutually adjusted in only two studies (35, 41) . The existing evidence does not suggest that one type of alcohol could be more related to leukemia risk than others.
One of the limitations of this study was that all the studies included in the meta-analyses were case-control studies. Recall bias due to the stigma of drinking during pregnancy cannot be excluded. Nevertheless, any recall bias should be assumed to operate similarly for studies on ALL or AML, and particularly in those investigating both types of leukemia. Another limitation concerns the control of potential confounding factors. In the case of AML in young children (Fig. 5) , the ORs were adjusted for maternal smoking during pregnancy in only two of five studies (24, 26) . Nevertheless, the size of the association reported in the tobacco-adjusted studies was similar to the estimates reported in the other studies. Other potentially uncontrolled confounding factors are maternal household use of pesticides, as suggested by Rudant et al. (41) , folate intake during pregnancy, birth weight, allergy after birth (55, 56) , and maternal age (57) . Study results were heterogeneous. It was not possible to statistically assess the source of heterogeneity using meta-regression analyses due to the low number of studies. Qualitative analysis of the data indicated that studies with a low number of cases exposed and low participation rates tended to report associations in opposite directions compared with other studies.
The association of maternal alcohol consumption during pregnancy and AML risk was observed in children ages 0 to 4 years (OR, 2.68; 95% CI, 1.85-3.89), which is consistent with the potential role of prenatal exposure to alcohol in the etiology of AML. The biological plausibility of this association is supported by the fact that alcoholic beverages are recognized as carcinogenic for humans (9) and are involved in several fetal alcohol-related diseases (11, 12) . The reason why in utero exposure to alcohol may specifically modify the risk of AML in young children is unknown. The incidence peak is observed at a younger age in AML compared with ALL, suggesting a stronger association or shorter latency of AML with prenatal exposures. However, a possible effect on subtypes of ALL and AML cannot be ruled out, as suggested recently for B mature or Burkitt ALL, with a few cases (41) and two studies in which the association of maternal alcohol intake for AML was predominant with M4/M5 subtypes (23) and M1/M2 subtypes (41), respectively. Although in most countries, pregnant women and women who are trying to conceive are advised to avoid drinking alcohol, to prevent fetal alcohol syndrome, recent studies indicate that the prevalence of women reporting alcohol drinking during pregnancy in some countries is still high: as reviewed by de Chazeron et al. (58) , it has been estimated to be 12% in the United States, 30% in Sweden, 52% in France, 59% in Australia, and 60% in Russia. Binge-drinking before pregnancy has been found to be a strong predictor of both drinking and binge-drinking during pregnancy (59) . In addition to actions directed to pregnant women, acting before pregnancy to reduce alcohol drinking might contribute to reduce the occurrence of harmful effects including AML in young children.
In the future, large birth cohort studies should investigate the influence of maternal alcohol drinking and the risk of childhood leukemia, in particular, AML. Such studies may integrate accurate data collection not only on fetal exposure to alcohol allowing doseresponse analyses, but also the collection of detailed potential confounding factors. Because ALL and AML are rare diseases, the creation of an international consortium of birth cohort studies could provide the statistical power required to investigate the interaction of alcohol drinking with other environmental and genetic factors in relation to the risk of acute leukemia in children.
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